Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial) |
| |
| Authors: | Michael Bö hm,Michele Robertson,Ian Ford,Jeffrey S. Borer,Michel Komajda,Ingrid Kindermann,Christoph Maack,Mitja Lainscak,Karl Swedberg,Luigi Tavazzi |
| |
| Affiliation: | 1. Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg (Saar), Germany;2. Robertson Centre for Biostatistics, University of Glasgow, Glasgow, United Kingdom;3. Division of Cardiovascular Medicine, The Howard Gilman Institute for Heart Valve Disease and the Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center, New York, New York;4. Institute of Cardiometabolism and Nutrition, Pierre et Marie Curie Paris VI University, La Pitié-Salpétrière Hospital, Paris, France;5. Department of Cardiology, General Hospital Celje, Celje, Slovenia;6. Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden;g Maria Cecilia Hospital, Gruppo Villa Maria (GVM) Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy |
| |
| Abstract: | ![]()
|
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
